Dormosedan
General Drug Information and Indications
Alpha-2 agonist (detomidine) for sedation and analgesia in horses; standing sedation for minor procedures; injectable and oral gel formulations.
Alpha-2 adrenergic agonist (detomidine HCl). Mechanism: potent and highly selective alpha-2 agonist → inhibits presynaptic norepinephrine release and postsynaptic adrenergic activity in the CNS → dose-dependent sedation, analgesia, and muscle relaxation. ~10× more potent than xylazine in horses. Available as injectable and oral gel formulations. No reversal agent approved in horses.
Key information
See Detomidine entry. Gel formulation: sublingual/oral mucosal — do not allow eating or drinking for 30 min after dosing. DEA Schedule III. Reversal: atipamezole.
How to Give this Medication
Injectable: administer IV or IM (horses). IV onset: 2–5 min; IM onset: 20–40 min. Oral gel (Dormosedan Gel): apply measured dose to the space between the cheek and gum using the calibrated syringe; do not allow horse to eat or drink for 30 min. Must be held 30–40 min for full effect — do not re-dose prematurely. Store at room temperature; protect from light.
If a dose is missed
This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.
Side Effects
Cardiovascular: bradycardia, AV block, initial peripheral vasoconstriction then vasodilation/hypotension. Respiratory: reduced rate and tidal volume. GI: decreased motility (ileus, colic risk — monitor horses). Diuresis. Sweating (horses). Ataxia. Penile prolapse (stallions). No approved reversal agent for horses.
Precautions
For animals
No approved reversal agent for horses. Monitor cardiac and respiratory function. Horses: keep head elevated; monitor for GI ileus. Oral gel: onset 40 min — do not re-dose prematurely. Stallions: penile prolapse risk.
For people handling this medication
Wear gloves when handling. Potent alpha-2 agonist sedative — avoid skin contact, especially with oral gel (highly concentrated). If skin contact occurs, wash immediately. If accidentally injected or ingested, seek emergency medical attention immediately. Do not drive or operate machinery after handling. Keep out of reach of children. Pregnant women and women of childbearing age should avoid contact. Keep out of reach of children.
Overdose
This is a veterinary emergency. Overdose causes severe cardiovascular and respiratory depression. Reversal agent (atipamezole) must be administered immediately by veterinary staff.
Dormosedan dosage forms
| Product | Strength | Form | Size | Type |
|---|---|---|---|---|
| DORMOSEDAN 10 MG/ML INJECTABLE | 10 MG/ML | Injectable | 1 | Commercial |
| DORMOSEDAN 5 ML 10 MG/ ML INJECTABLE | 10 MG/ML | Injectable | 1 | Commercial |
| DORMOSEDAN GEL 3.0 ML 7.6MG/ML GEL | 7.6 MG/ML | Gel | 1 | Commercial |
Sources
This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Merck Veterinary Manual (merckvetmanual.com); Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com)